Portal de Periódicos da CAPES

Colitis May Be Part of the Antiepileptic Drug Hypersensitivity Syndrome

1999; Wiley; Volume: 40; Issue: 12 Linguagem: Inglês

10.1111/j.1528-1157.1999.tb01598.x

1528-1167

Ingo A. Eland, Anton S. M. Dofferhoff, Matthijs Vink, Pieter E. Zondervan, Bruno H. Stricker,

Pneumocystis jirovecii pneumonia detection and treatment

Summary: Purpose: To show that colitis may be part of the antiepileptic hypersensitivity syndrome. Methods: Description of two case histories. Results: The first patient was a 47‐year‐old man who developed fever, lymphadenopathy, influenza‐like symptoms, facial edema, skin rash and diarrhea after 3 weeks of carbamazepine (CBZ) treatment. Laparotomy because of severe abdominal pain 2 weeks later showed severe colitis with perforations. The second patient was a 41‐year‐old woman who developed fever, diarrhea, and skin rash 4 weeks after start of CBZ treatment. A colon biopsy confirmed colitis. Stool examinations did not show pathogenic microorganisms, and there was no evidence of Crohn's disease or ulcerative colitis. Both patients had elevated liver enzymes, peripheral eosinophilia, and eosinophils in the infiltrate of the colon. Conclusions: In view of the close temporal relation between start of CBZ intake and development of colitis, the presence of fever, lymphadenopathy, and rash, and improvement after discontinuation of CBZ, we conclude that the two patients developed an AED hypersensitivity syndrome. Our case histories demonstrate that severe colitis may be part of this syndrome.